Table 2 Characteristics of participants
Characteristics | Whole Cohort | Male | Female | P |
|---|---|---|---|---|
Participants | 612 | 386 | 226 | Â |
Age (Years) | 73 (68,80) | 75 (69,82) | 72 (68,77) | 0.000* |
BSA(m2) | 1.61 (1.48,1.74) | 1.69 (1.56,1.81) | 1.52 (1.42,1.52) | 0.000* |
Scr (μmol/l) | 119.62 (86.00,190.80) | 132.60 (89.60,183.71) | 106.50 (74.0,205.8) | 0.001* |
Bun (mmol/l) | 8.18 (6.10,12.18) | 8.10(6.17,11.52) | 8.26 (6.00,13.13) | 0.927* |
Alb(g/l) | 34.80 (30.70,38.30) | 34.60 (30.70,38.00) | 35.10 (30.38,39.00) | 0.439* |
Year group, n(%) | ||||
65–79 Year | 444 (70.13) | 256 (65.20) | 188 (79.36) | 0.000** |
≥80 | 168 (29.87) | 130 (34.80) | 38 (20.64) |  |
mGFR (ml/min/1.73 m2) | 42.1 (27.4,62.1) | 43.7 (27.9,61.2) | 40.1 (25.6,59.2) | 0.080* |
mGFR, n(%) | ||||
  ≥ 90 ml/min/1.73 m2 | 32 (5.2) | 21 (5.4) | 11 (4.9) |  |
 60–89 ml/min/1.73 m2 | 126 (20.6) | 82 (21.2) | 44 (19.5) |  |
 30–59 ml/min/1.73 m2 | 266 (43.5) | 175 (45.3) | 91 (40.3) |  |
 15–29 ml/min/1.73 m2 | 146 (23.9) | 90 (23.3) | 56 (24.8) |  |
  < 15 ml/min/1.73 m2 | 42 (6.9) | 18 (4.7) | 24 (10.6) |  |
eGFR (ml/min/1.73 m2) | ||||
 CKD-EPI equation | 44.4 (27.1,67.0) | 44.8 (29.3,65.8) | 43.8 (20.0,69.4) | 0.390* |
 LMR equation | 41.1 (23.9,59.9) | 40.9 (25.0,60.0) | 41.5 (18.8,63.6) | 0.799* |
 BIS1 equation | 43.6 (30.0,59.5) | 43.4 (31.8,57.7) | 44.3 (25.0,61.0) | 0.778* |
 FAS equation | 41.8 (27.7,59.3) | 42.1 (29.6,58.8) | 41.3 (21.8,60.6) | 0.391* |
 EKFC equation | 41.9 (26.4,61.6) | 42.2 (28.1,61,1) | 40.8 (19.6,64.5) | 0.305* |
Causes of kidney disease, n(%) | ||||
 Primary glomerular disease | 101 (16.5) | 49 (12.7) | 52 (23.0) | 0.000** |
 Diabetic nephropathy | 164 (26.8) | 105 (27.2) | 59 (26.1) | 0.000** |
 Hypertensive nephrosclerosis | 84 (13.7) | 60 (15.5) | 24 (10.6) | 0.000** |
 Obstructive nephropathy | 100 (16.3) | 49 (12.7) | 51 (22.6) | 0.000** |
 Others | 163 (26.6) | 123 (31.9) | 40 (17.7) | 0.000** |
Comorbid condition (%) | ||||
 Hypertension | 460 (75.2) | 286 (74.1) | 174 (77.0) | 0.000** |
 Diabetes | 293 (47.9) | 189 (49.0) | 104 (46.2) | 0.000** |
 Coronary heart disease | 225 (36.8) | 159 (41.2) | 66 (29.2) | 0.000** |
 Cerebrovascular disease | 133 (21.7) | 103 (26.7) | 30 (13.3) | 0.000** |